Chipway Technology (Chengdu) Co., Ltd. is currently in the process of developing a high-channel-density EEG acquisition AFE chip tailored for non-invasive brain-computer interfaces, with an anticipated release date in the first half of 2027. This chip stands out as the industry's pioneering high-performance 32-channel acquisition chip, meticulously engineered to gather and scrutinize human brain electrophysiological signals with exceptional quality, thereby paving the way for seamless information exchange between the brain and external devices. Established in 2021, Chipway Technology has dedicated itself to the research and development of high-performance signal chain chips, with its products finding applications across diverse sectors. Historically, domestic non-invasive brain-computer interface devices have predominantly depended on overseas acquisition chips, a reliance that has been fraught with challenges such as substantial price volatility and extended lead times. Chipway Technology is steadily advancing chip localization efforts, and its proprietary single-chip solution promises to diminish device size and power consumption, thereby expediting the commercialization of non-invasive brain-computer interfaces. Furthermore, the burgeoning brain-computer interface industry cluster in Chengdu is rapidly taking shape, offering a conducive industrial ecosystem for the growth and development of Chipway Technology.